The global market for NGS-Based RNA-Sequencing is estimated at US$2.4 Billion in 2023 and is projected to reach US$8.6 Billion by 2030, growing at a CAGR of 20.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Sequencing Platforms & Consumables segment, which is expected to reach US$4.6 Billion by 2030 with a CAGR of a 20.6%. The Sample Preparation segment is also set to grow at 17.4% CAGR over the next 7 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $712.1 Million in 2023, and China, forecasted to grow at an impressive 18.8% CAGR to reach $1.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global NGS-Based RNA-Sequencing Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global NGS-Based RNA-Sequencing Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global NGS-Based RNA-Sequencing Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Agilent Technologies, Inc., Eurofins Scientific, F. Hoffmann-La Roche AG, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 46 Featured):
- Agilent Technologies, Inc.
- Eurofins Scientific
- F. Hoffmann-La Roche AG
- GATC Biotech AG
- Illumina, Inc.
- Macrogen, Inc.
- Oxford Nanopore Technologies Ltd.
- Pacific Biosciences of California, Inc.
- PerkinElmer, Inc.
- Qiagen NV
- Thermo Fisher Scientific, Inc.
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- RNA-Seq: An Introduction
- A Prelude to NGS-based RNA-seq Market
- North America: The Largest Market for NGS-based RNA-seq
- NGS-based RNA-seq - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
3. MARKET TRENDS & DRIVERS
- NGS-based RNA-seq Market Drivers and Restraints
- Recent Advances in RNA Sequence Analysis
- Select Players of NGS-based RNA-seq Market
- Rise in Research Grants to Improve Activities in NGS-based RNA-Sequencing Technique
- Application of RNA-Seq in Precision Medicine
- Next Generation Sequencing in Cancer Research
- Next Generation Sequencing for Transcriptomic Profiling
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Sequencing by Synthesis (SBS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 2: World 7-Year Perspective for Sequencing by Synthesis (SBS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 3: World Recent Past, Current & Future Analysis for Ion Semiconductor Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 4: World 7-Year Perspective for Ion Semiconductor Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 5: World Recent Past, Current & Future Analysis for Single-molecule Real-time (SMRT) Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 6: World 7-Year Perspective for Single-molecule Real-time (SMRT) Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 8: World 7-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 9: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 10: World 7-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 12: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Sequencing Platforms & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 14: World 7-Year Perspective for Sequencing Platforms & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 15: World Recent Past, Current & Future Analysis for Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 16: World 7-Year Perspective for Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 17: World Recent Past, Current & Future Analysis for Sequencing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 18: World 7-Year Perspective for Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Data Analysis, Storage & Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 20: World 7-Year Perspective for Data Analysis, Storage & Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 21: World Recent Past, Current & Future Analysis for Research Centers & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 22: World 7-Year Perspective for Research Centers & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 23: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 24: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 25: World NGS-Based RNA-Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- Table 26: World Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 27: World 7-Year Perspective for NGS-Based RNA-Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
UNITED STATES
- NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 28: USA Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 29: USA 7-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2024 & 2030
- Table 30: USA Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 31: USA 7-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2024 & 2030
- Table 32: USA Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 33: USA 7-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2024 & 2030
CANADA
- Table 34: Canada Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 35: Canada 7-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2024 & 2030
- Table 36: Canada Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 37: Canada 7-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2024 & 2030
- Table 38: Canada Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 39: Canada 7-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2024 & 2030
JAPAN
- NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 40: Japan Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 41: Japan 7-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2024 & 2030
- Table 42: Japan Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 43: Japan 7-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2024 & 2030
- Table 44: Japan Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 45: Japan 7-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2024 & 2030
CHINA
- NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 46: China Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 47: China 7-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2024 & 2030
- Table 48: China Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 49: China 7-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2024 & 2030
- Table 50: China Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 51: China 7-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2024 & 2030
EUROPE
- NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 52: Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 53: Europe 7-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2024 & 2030
- Table 54: Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 55: Europe 7-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2024 & 2030
- Table 56: Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 57: Europe 7-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2024 & 2030
- Table 58: Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 59: Europe 7-Year Perspective for NGS-Based RNA-Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
FRANCE
- NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 60: France Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 61: France 7-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2024 & 2030
- Table 62: France Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 63: France 7-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2024 & 2030
- Table 64: France Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 65: France 7-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2024 & 2030
GERMANY
- NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 66: Germany Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 67: Germany 7-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2024 & 2030
- Table 68: Germany Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 69: Germany 7-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2024 & 2030
- Table 70: Germany Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 71: Germany 7-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2024 & 2030
ITALY
- Table 72: Italy Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 73: Italy 7-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2024 & 2030
- Table 74: Italy Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 75: Italy 7-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2024 & 2030
- Table 76: Italy Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 77: Italy 7-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2024 & 2030
UNITED KINGDOM
- NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 78: UK Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 79: UK 7-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2024 & 2030
- Table 80: UK Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 81: UK 7-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2024 & 2030
- Table 82: UK Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 83: UK 7-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2024 & 2030
REST OF EUROPE
- Table 84: Rest of Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 85: Rest of Europe 7-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2024 & 2030
- Table 86: Rest of Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 87: Rest of Europe 7-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2024 & 2030
- Table 88: Rest of Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 89: Rest of Europe 7-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2024 & 2030
ASIA-PACIFIC
- NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 90: Asia-Pacific Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 91: Asia-Pacific 7-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2024 & 2030
- Table 92: Asia-Pacific Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 93: Asia-Pacific 7-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2024 & 2030
- Table 94: Asia-Pacific Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 95: Asia-Pacific 7-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2024 & 2030
REST OF WORLD
- Table 96: Rest of World Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 97: Rest of World 7-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2024 & 2030
- Table 98: Rest of World Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 99: Rest of World 7-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2024 & 2030
- Table 100: Rest of World Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 101: Rest of World 7-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2024 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies, Inc.
- Eurofins Scientific
- F. Hoffmann-La Roche AG
- GATC Biotech AG
- Illumina, Inc.
- Macrogen, Inc.
- Oxford Nanopore Technologies Ltd.
- Pacific Biosciences of California, Inc.
- PerkinElmer, Inc.
- Qiagen NV
- Thermo Fisher Scientific, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 196 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 2.4 Billion |
| Forecasted Market Value ( USD | $ 8.6 Billion |
| Compound Annual Growth Rate | 20.1% |
| Regions Covered | Global |
